Celldex Therapeutics, Inc.
CLDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$158 | -$141 | -$112 | -$71 |
| Dep. & Amort. | $3 | $3 | $1 | $3 |
| Deferred Tax | $0 | $0 | $0 | -$0 |
| Stock-Based Comp. | $34 | $24 | $0 | $9 |
| Change in WC | -$22 | $13 | -$4 | -$1 |
| Other Non-Cash | -$16 | -$6 | $11 | -$1 |
| Operating Cash Flow | -$158 | -$107 | -$104 | -$61 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$2 | -$2 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$790 | -$425 | -$189 | -$390 |
| Inv. Sales/Matur. | $502 | $321 | $281 | $175 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$290 | -$106 | $90 | -$216 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $432 | $216 | $4 | $270 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $9 | $2 | $0 | $2 |
| Financing Cash Flow | $441 | $218 | $4 | $272 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$6 | $5 | -$10 | -$5 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $35 | $29 | $39 | $44 |
| End Cash | $28 | $35 | $29 | $39 |
| Free Cash Flow | -$160 | -$109 | -$106 | -$62 |